Cargando…
Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
BACKGROUND AND AIM: Type 2 diabetes (T2D) in associated with higher prevalence and worse outcomes of nonalcoholic fatty liver disease (NAFLD). However, data regarding the prevalence of clinically relevant liver fibrosis (CRLF) in Indian individuals with T2D are scarce. We investigated the prevalence...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341185/ https://www.ncbi.nlm.nih.gov/pubmed/34386600 http://dx.doi.org/10.1002/jgh3.12606 |
_version_ | 1783733878931849216 |
---|---|
author | Kuchay, Mohammad Shafi Choudhary, Narendra Singh Mishra, Sunil Kumar Bano, Tarannum Gagneja, Sakshi Mathew, Anu Singh, Manish Kumar Kaur, Parjeet Gill, Harmandeep Kaur Wasir, Jasjeet Singh Sud, Randhir Mithal, Ambrish |
author_facet | Kuchay, Mohammad Shafi Choudhary, Narendra Singh Mishra, Sunil Kumar Bano, Tarannum Gagneja, Sakshi Mathew, Anu Singh, Manish Kumar Kaur, Parjeet Gill, Harmandeep Kaur Wasir, Jasjeet Singh Sud, Randhir Mithal, Ambrish |
author_sort | Kuchay, Mohammad Shafi |
collection | PubMed |
description | BACKGROUND AND AIM: Type 2 diabetes (T2D) in associated with higher prevalence and worse outcomes of nonalcoholic fatty liver disease (NAFLD). However, data regarding the prevalence of clinically relevant liver fibrosis (CRLF) in Indian individuals with T2D are scarce. We investigated the prevalence of, and factors associated with, CRLF in Indians with T2D. METHODS: We conducted a prospective study of 601 consecutive adults with T2D. Steatosis was diagnosed using ultrasonography. Liver stiffness measurement (LSM) by transient elastography of ≥8.0 kPa was taken as cutoff suggesting CRLF. Individuals with LSM > 13.0 kPa underwent dynamic magnetic resonance imaging (MRI) of liver for detecting changes consistent with cirrhosis. RESULTS: The prevalence of steatosis was 84.2%. Higher body mass index (BMI, P = 0.022), alanine aminotransferase (ALT; P = 0.001), and lower high‐density lipoprotein (HDL; P = 0.002) were independent factors associated with steatosis. The prevalence of CRLF was 28.2%. Higher BMI (P = 0.001), aspartate aminotransferase (AST; P < 0.0001), gamma‐glutamyl transpeptidase (GGT; P < 0.0001), and concomitant hypertension (P = 0.03) were independent factors associated with CRLF. Elevated ALT and AST (≥40 units/L) levels were present in 70.6 and 51.6% individuals with CRLF, respectively. Thirty‐one (7.2%) individuals had LSM > 13.0 kPa. Among them, 25 individuals underwent dynamic MRI of liver, which revealed features consistent with cirrhosis in 18 patients. CONCLUSION: CRLF, an established risk factor for cirrhosis and overall mortality, affects at least one out of four (25%) Indians with T2D. These results support screening of all patients with T2D and NAFLD for liver fibrosis. |
format | Online Article Text |
id | pubmed-8341185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wiley Publishing Asia Pty Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-83411852021-08-11 Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes Kuchay, Mohammad Shafi Choudhary, Narendra Singh Mishra, Sunil Kumar Bano, Tarannum Gagneja, Sakshi Mathew, Anu Singh, Manish Kumar Kaur, Parjeet Gill, Harmandeep Kaur Wasir, Jasjeet Singh Sud, Randhir Mithal, Ambrish JGH Open Original Articles BACKGROUND AND AIM: Type 2 diabetes (T2D) in associated with higher prevalence and worse outcomes of nonalcoholic fatty liver disease (NAFLD). However, data regarding the prevalence of clinically relevant liver fibrosis (CRLF) in Indian individuals with T2D are scarce. We investigated the prevalence of, and factors associated with, CRLF in Indians with T2D. METHODS: We conducted a prospective study of 601 consecutive adults with T2D. Steatosis was diagnosed using ultrasonography. Liver stiffness measurement (LSM) by transient elastography of ≥8.0 kPa was taken as cutoff suggesting CRLF. Individuals with LSM > 13.0 kPa underwent dynamic magnetic resonance imaging (MRI) of liver for detecting changes consistent with cirrhosis. RESULTS: The prevalence of steatosis was 84.2%. Higher body mass index (BMI, P = 0.022), alanine aminotransferase (ALT; P = 0.001), and lower high‐density lipoprotein (HDL; P = 0.002) were independent factors associated with steatosis. The prevalence of CRLF was 28.2%. Higher BMI (P = 0.001), aspartate aminotransferase (AST; P < 0.0001), gamma‐glutamyl transpeptidase (GGT; P < 0.0001), and concomitant hypertension (P = 0.03) were independent factors associated with CRLF. Elevated ALT and AST (≥40 units/L) levels were present in 70.6 and 51.6% individuals with CRLF, respectively. Thirty‐one (7.2%) individuals had LSM > 13.0 kPa. Among them, 25 individuals underwent dynamic MRI of liver, which revealed features consistent with cirrhosis in 18 patients. CONCLUSION: CRLF, an established risk factor for cirrhosis and overall mortality, affects at least one out of four (25%) Indians with T2D. These results support screening of all patients with T2D and NAFLD for liver fibrosis. Wiley Publishing Asia Pty Ltd 2021-06-29 /pmc/articles/PMC8341185/ /pubmed/34386600 http://dx.doi.org/10.1002/jgh3.12606 Text en © 2021 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Kuchay, Mohammad Shafi Choudhary, Narendra Singh Mishra, Sunil Kumar Bano, Tarannum Gagneja, Sakshi Mathew, Anu Singh, Manish Kumar Kaur, Parjeet Gill, Harmandeep Kaur Wasir, Jasjeet Singh Sud, Randhir Mithal, Ambrish Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title_full | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title_fullStr | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title_full_unstemmed | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title_short | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes |
title_sort | prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in indian individuals with type 2 diabetes |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341185/ https://www.ncbi.nlm.nih.gov/pubmed/34386600 http://dx.doi.org/10.1002/jgh3.12606 |
work_keys_str_mv | AT kuchaymohammadshafi prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT choudharynarendrasingh prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT mishrasunilkumar prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT banotarannum prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT gagnejasakshi prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT mathewanu prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT singhmanishkumar prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT kaurparjeet prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT gillharmandeepkaur prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT wasirjasjeetsingh prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT sudrandhir prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes AT mithalambrish prevalenceofclinicallyrelevantliverfibrosisduetononalcoholicfattyliverdiseaseinindianindividualswithtype2diabetes |